News Agency
The Times

Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA

  • Written by PR Newswire
Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
  • Enabled by Altruist's integrated CMC development platform, GMP manufacturing and regulatory service capabilities, LP-003 has successfully advanced from concept to potential commercialization.
  • LP-003 is the first innovative drug independently developed by LongBio Pharma to advance to BLA submission.

HANGZHOU, China, Sept. 14, 2026 /PRNewswire/ --...

Read more: Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the...

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion